CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities
Net loss	$ (1,610,304)	$ (1,600,399)
Adjustments to reconcile net loss to cash used in operating activities
Depreciation and amortization	8,651	9,657
Bad debt	1,276	(25,844)
Gain on disposition	0	(50,839)
Amortization of debt discount	137,412	117,515
Loss on settlement of non-redeemable convertible notes	641,562	666,305
Change in operating assets and liabilities
Accounts and taxes receivable	(4,603)	(48,953)
Prepaid expense	10,000	0
Inventory	(3,600)	14,979
Deferred revenue	0	(22,284)
Accounts payable and accrued liabilities	586,822	573,590
Operating lease right-of-use liability	(6,373)	(6,191)
Net cash used in operating activities	(239,157)	(372,464)
Cash flows from investing activities
Net cash used in investing activities	0	0
Cash flow from financing activities
Expenses paid for by related party	61,748	77,490
Repayment of advances to related party	(25,432)	(27,379)
Proceeds from notes payable	0	105,299
Repayment of notes payable	0	(7,057)
Proceeds from line of credit	190,976	234,417
Net cash provided by financing activities	227,292	382,770
Change in foreign exchange	(528)	(123)
Net change in cash	(12,393)	10,183
Cash, beginning of the period	24,351	17,137
Cash, end of the period	11,958	27,320
Cash paid during the period
Interest paid	0	0
Income taxes paid	0	0
Supplemental disclosure of non-cash investing and financing activities
Stock issued for settlement of debt - related party	296,000	188,871
Stock issued for settlement of promissory notes	17,500	0
Stock issued for settlement of promissory notes - related party	0	85,922
Stock issued to settle non-redeemable convertible notes	821,094	783,500
Issue of promissory notes to settle other promissory notes	240,926	0
Deemed contribution - Series A Stock Modification	0	190,040
Deemed contribution - Series C Stock Modification	$ 0	$ 2,211,884